This session will be geared towards drug and device manufacturers and technology companies and will provide attendees with an understanding of what constitutes digital health and health information technology; how the federal anti-kickback statute, the federal false claims act, HIPAA and other laws apply in the digital world; and best practices for compliance.

This is Part 4 of a six-part series. Part 1, The Ebb and Flow of the Law – A Year of Drug, Medical Device, and Vaccine-Related Preemption Developments is taking place on November 7, 2022, Part 2, Ethics and E-Discovery: Lessons Learned from the Alex Jones Case and Others is taking place on November 8, 2022, Part 3, Current Trends in Today’s Pharma and Device Litigation is taking place on November 9, 2022, Part 5, Warning Causation: Taxonomy and Tactics is taking place on November 10, 2022, and Part 6, MDL Trends is taking place on November 10, 2022.

CLE Information: This webinar is presumptively approved for 1.0 CLE credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas and West Virginia. Applications for CLE credit will be filed in Florida, Ohio, and Virginia. Attendees who are licensed in other jurisdictions will receive a uniform certificate of attendance but Reed Smith only provides credit for the states listed. Please allow 4-6 weeks after the program to receive a certificate of attendance.